- Home
- ORGO vs LDP Comparison
ORGO vs LDP Comparison
Compare ORGO & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- LDP
- Stock Information
- Founded
- ORGO 1985
- LDP 2012
- Country
- ORGO United States
- LDP United States
- Employees
- ORGO N/A
- LDP N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- ORGO Health Care
- LDP Finance
- Exchange
- ORGO Nasdaq
- LDP Nasdaq
- Market Cap
- ORGO 665.8M
- LDP 549.6M
- IPO Year
- ORGO N/A
- LDP N/A
- Fundamental
- Price
- ORGO $4.45
- LDP $19.41
- Analyst Decision
- ORGO Buy
- LDP
- Analyst Count
- ORGO 2
- LDP 0
- Target Price
- ORGO $5.50
- LDP N/A
- AVG Volume (30 Days)
- ORGO 1.4M
- LDP 102.5K
- Earning Date
- ORGO 05-08-2025
- LDP 01-01-0001
- Dividend Yield
- ORGO N/A
- LDP 7.91%
- EPS Growth
- ORGO N/A
- LDP N/A
- EPS
- ORGO N/A
- LDP N/A
- Revenue
- ORGO $482,043,000.00
- LDP N/A
- Revenue This Year
- ORGO $3.31
- LDP N/A
- Revenue Next Year
- ORGO $12.50
- LDP N/A
- P/E Ratio
- ORGO N/A
- LDP N/A
- Revenue Growth
- ORGO 11.29
- LDP N/A
- 52 Week Low
- ORGO $2.17
- LDP $16.16
- 52 Week High
- ORGO $6.71
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- ORGO 52.57
- LDP 45.37
- Support Level
- ORGO $4.11
- LDP $19.12
- Resistance Level
- ORGO $4.38
- LDP $19.36
- Average True Range (ATR)
- ORGO 0.35
- LDP 0.44
- MACD
- ORGO 0.03
- LDP 0.05
- Stochastic Oscillator
- ORGO 80.17
- LDP 53.39
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.